FDA Warning Letter — Louisville Reproductive Center
The FDA took a Warning Letter action against Louisville Reproductive Center on January 23, 2026 (Louisville, KY). The action was issued by CBER and concerns biologics products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Louisville Reproductive Center
- Date
- January 23, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Center
- CBER
- Location
- Louisville, KY (United States)